Compound Detail
CHEMBL254328
ABIRATERONE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12
Basic Information
| ChEMBL ID | CHEMBL254328 |
| Name | ABIRATERONE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | GZOSMCIZMLWJML-VJLLXTKPSA-N |
| Therapeutic | ✓ Yes |
17
Targets
66
Activities
1
Assay Types
8
PK Parameters
20
Publications
6
Known Names
7
Indications
3
Mechanisms
Molecular Properties
349.5
MW (Da)
5.40
ALogP
2
HBA
1
HBD
33.1
PSA (Ų)
0.69
QED
1
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cytochrome P450 17A1 inhibitor | INHIBITOR | Steroid 17-alpha-hydroxylase/17,20 lyase | ✓ | ✓ |
| Androgen Receptor antagonist | ANTAGONIST | Androgen receptor | ✓ | ✓ |
| Steroid 5-alpha-reductase inhibitor | INHIBITOR | Steroid 5-alpha-reductase | ✓ | ✓ |
Indications
Neoplasms Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant
ATC Classification
L02BX03
abiraterone
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ENDOCRINE THERAPY
Activity Summary
IC50 66 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Steroid 17-alpha-hydroxylase/17,20 lyase CHEMBL3522 | IC50 | 8.7 | 7.4296 | 2.0 | 26 |
| Steroid 17-alpha-hydroxylase/17,20 lyase CHEMBL4430 | IC50 | 7.9 | 7.5175 | 12.5 | 4 |
| Steroid 21-hydroxylase CHEMBL2759 | IC50 | 7.49 | 6.85 | 32.4 | 3 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 6.64 | 5.7483 | 230.0 | 6 |
| Cytochrome P450 11B1, mitochondrial CHEMBL1908 | IC50 | 5.79 | 5.79 | 1608.0 | 4 |
| Cytochrome P450 11B2, mitochondrial CHEMBL2722 | IC50 | 5.76 | 5.76 | 1750.0 | 3 |
| LNCaP CHEMBL612518 | IC50 | 5.57 | 5.525 | 2706.0 | 2 |
| PC-3 CHEMBL390 | IC50 | 5.23 | 4.765 | 5940.0 | 4 |
| MGC-803 CHEMBL3706566 | IC50 | 5.11 | 5.11 | 7720.0 | 1 |
| CWR22R CHEMBL612657 | IC50 | 5.04 | 5.04 | 9090.0 | 1 |
| GES1 CHEMBL4296415 | IC50 | 4.88 | 4.88 | 13120.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.77 | 4.7225 | 16900.0 | 4 |
| HeLa CHEMBL399 | IC50 | 4.77 | 4.77 | 16900.0 | 1 |
| T47D CHEMBL614361 | IC50 | 4.46 | 4.46 | 34700.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.42 | 4.42 | 38200.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.22 | 4.22 | 59800.0 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 4.22 | 4.22 | 59500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 4015.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 186.83 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 54.95 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| Cmax | 1693.75 | nM | Rattus norvegicus |
| Cmax | 90.0 | nM | Homo sapiens |
| T1/2 | 1.6 | hr | Rattus norvegicus |
| T1/2 | 0.01667 | hr | Homo sapiens |
| Tmax | 2.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine